It is sold in Europe under the brand names Neupramir, Pramistar, and Remen and is prescribed there for treatment of dyslexia, ADHD, dementia and memory problems caused by Alzheimer's disease and other neurological conditions.
ມັນຖືກຂາຍຢູ່ໃນເອີຣົບພາຍໃຕ້ຊື່ແບ Neupramir, Pramistar ແລະ Remen ແລະຖືກກໍານົດໄວ້ສໍາລັບການປິ່ນປົວ dyslexia, ADHD, dementia ແລະບັນຫາກ່ຽວກັບຄວາມຈໍາທີ່ເກີດຈາກພະຍາດ Alzheimer ແລະສະພາບ neurological ອື່ນໆ.